|
Mar 4
|
Is Perrigo (PRGO) the Best Weight Loss Drug Stock to Buy According to Analysts?
|
|
Mar 1
|
Why Perrigo Company plc (PRGO) Soared on Friday
|
|
Mar 1
|
Perrigo Full Year 2024 Earnings: Misses Expectations
|
|
Feb 28
|
Perrigo's Q4 Earnings Beat Estimates, Revenues Decline Y/Y
|
|
Feb 28
|
Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual Investor Day
|
|
Feb 28
|
Perrigo (PRGO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Feb 27
|
Perrigo (PRGO) Q4 Earnings Beat Estimates
|
|
Feb 27
|
Perrigo: Q4 Earnings Snapshot
|
|
Feb 27
|
Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations
|
|
Feb 26
|
Perrigo to Attend the UBS 2025 Global Consumer and Retail Conference
|
|
Feb 25
|
Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect
|
|
Feb 25
|
Countdown to Perrigo (PRGO) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
|
|
Feb 4
|
Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and expansion of partnerships
|
|
Jan 6
|
Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer
|